Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer: future directions.

Wah K Lam1, D Neil Watkins

  • 1Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China.

Respirology (Carlton, Vic.)
|June 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancer.

Nature immunology·2024
Same author

Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.

Oncogene·2023
Same author

MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.

Journal of experimental & clinical cancer research : CR·2023
Same author

SILAC kinase screen identifies potential MASTL substrates.

Scientific reports·2022
Same author

Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice.

Biochimica et biophysica acta. Molecular basis of disease·2022
Same author

Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.

Oncogene·2021
Same journal

High-Flow Nasal Oxygen in Early Home Pulmonary Rehabilitation for Exertional Hypoxaemia: A Pilot Randomised Feasibility Trial.

Respirology (Carlton, Vic.)·2026
Same journal

Contemporary Concise Review 2025: Asthma.

Respirology (Carlton, Vic.)·2026
Same journal

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

Respirology (Carlton, Vic.)·2026
Same journal

Clinical and Inflammatory Phenotypes During Exacerbations Predict In-Hospital Adverse Outcomes in Asthma-COPD Overlap.

Respirology (Carlton, Vic.)·2026
Same journal

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study.

Respirology (Carlton, Vic.)·2026
Same journal

Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre-COPD.

Respirology (Carlton, Vic.)·2026
See all related articles

Basic lung cancer research is translating into clinical benefits through targeted therapies and molecular profiling. These advances promise improved risk assessment, early detection, and personalized treatment plans for better patient outcomes.

Area of Science:

  • Oncology
  • Translational Medicine

Background:

  • Basic lung cancer research is increasingly yielding clinical applications.
  • Targeted therapies, including tyrosine kinase and angiogenesis inhibitors, are being refined.
  • Understanding cancer biology offers potential for improved risk assessment, early detection, and novel treatments.

Purpose of the Study:

  • To review the translational promise of basic lung cancer research.
  • To highlight the role of targeted agents and cancer stem cells.
  • To discuss the impact of molecular profiling on individualized patient care.

Main Methods:

  • Review of recent studies on targeted therapies and predictive factors.
  • Exploration of basic lung cancer biology, including apoptotic and developmental pathways.

Related Experiment Videos

  • Discussion of the cancer stem cell phenomenon and molecular profiling.

    • Main Results:

    • Targeted therapies show promise with elucidated predictive factors.
    • New agents targeting cancer vulnerabilities are under development.
    • Cancer stem cell research may offer new strategies for recurrence prevention and disease control.

    Conclusions:

    • Molecular profiling enables highly individualized prognostic, predictive, and therapeutic plans.
    • Advances in genetic susceptibility, early detection, and personalized therapy are crucial for future lung cancer management.
    • Translational research holds significant promise for improving lung cancer patient outcomes.